Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation

Molecular and Cellular Endocrinology

Volumn 399, Issue , 2015, Pages 321-329

  Zou, Jian ^a   Gan, Xiaohong ^a   Zhou, Houfeng ^a   Chen, Xiaoxiao ^a   Guo, Yuanxin ^a   Chen, Jia ^a   Yang, Xiaolai ^b   Lei, Jianguo ^a  

^a CHENGDU FIFTH PEOPLE S HOSPITAL   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Alpha lipoic acid; C EBP ; Cardiac hypertrophy

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CCAAT ENHANCER BINDING PROTEIN BETA; PHENYLEPHRINE; THIOCTIC ACID; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CEBPB PROTEIN, RAT; VITAMIN B COMPLEX;

ANF GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTROPHIC ACTIVITY; ARTICLE; BNP GENE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARDIOMEGALY; DOWN REGULATION; DRUG EFFECTS; HEART MUSCLE CELL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANIMALS; CARDIOMEGALY; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DOWN-REGULATION; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; THIOCTIC ACID; VITAMIN B COMPLEX;

EID: 84909606207     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.10.003     Document Type: Article

References (28)

1. Boström P., Mann N., Wu J., Quintero P.A., Plovie E.R., Panakova D., et al. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143:1072-1083.
2. Chen L., Chen C.X., Gan X.T., Beier N., Scholz W., Karmazyn M. Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition. Am. J. Physiol. Heart Circ. Physiol 2004, 286:H381-H387.
3. Deng C., Sun Z., Tong G., Yi W., Ma L., Zhao B., et al. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway. PLoS ONE 2013, 8:e58371.
4. Ghibu S., Richard C., Vergely C., Zeller M., Cottin Y., Rochette L. Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J. Cardiovasc. Pharmacol 2009, 54:391-398.
5. Harada K., Komuro I., Shiojima I., Hayashi D., Kudoh S., Mizuno T., et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1998, 97:1952-1959.
6. Hegazy S.K., Tolba O.A., Mostafa T.M., Eid M.A., El-Afify D.R. Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev. Diabet. Stud 2013, 10:58-67.
7. Hill J.A., Olson E.N. Cardiac plasticity. N. Engl. J. Med 2008, 358:1370-1380.
8. Huang G.N., Thatcher J.E., McAnally J., Kong Y., Qi X., Tan W., et al. C/EBP transcription factors mediate epicardial activation during heart development and injury. Science 2012, 338:1599-1603.
9. Lee J.E., Yi C.O., Jeon B.T., Shin H.J., Kim S.K., Jung T.S., et al. α-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Cardiovasc. Diabetol 2012, 11:111.
10. Li C.J., Lv L., Li H., Yu D.M. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc. Diabetol 2012, 11:73.
11. Lin Y.C., Lai Y.S., Chou T.C. The protective effect of alpha-lipoic acid in lipopolysaccharide-induced acute lung injury is mediated by heme oxygenase-1. Evid. Based Complement. Alternat. Med 2013, 2013:590363.
12. Liu Q., Chen Y., Auger-Messier M., Molkentin J.D. Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ. Res 2012, 110:1077-1086.
13. Louhelainen M., Merasto S., Finckenberg P., Lapatto R., Cheng Z.J., Mervaala E.M. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J. Hypertens 2006, 24:947-956.
14. Mijnhout G.S., Alkhalaf A., Kleefstra N., Bilo H.J. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes?. Neth. J. Med 2010, 68:158-162.
15. Moon K.Y., Hahn B.S., Lee J., Kim Y.S. A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal. Biochem 2001, 292:17-21.
16. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007, 17:318-324.
17. Ogborne R.M., Rushworth S.A., O'Connell M.A. Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells. Arterioscler. Thromb. Vasc. Biol 2005, 25:2100-2105.
18. Oh M., Dey A., Gerard R.D., Hill J.A., Rothermel B.A. The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4. J. Biol. Chem 2010, 285:16623-16631.
19. Prasad A.M., Inesi G. Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes. Am. J. Physiol. Cell Physiol 2009, 296:C992-C1002.
20. Rui W., Jin Z., Zhe G., Song H. The methylation of C/EBP beta gene promoter and regulated by GATA-2 protein. Mol. Biol. Rep 2013, 40:797-801.
21. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557-567.
22. Singh U., Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr. Rev 2008, 66:646-657.
23. Stastna M., Van Eyk J.E. Optimized method for identification of the proteomes secreted by cardiac cells. Methods Mol. Biol 2013, 1005:225-235.
24. Xu J., Yang W., Deng Q., Huang Q., Yang J., Huang F. Flaxseed oil and alpha-lipoic acid combination reduces atherosclerosis risk factors in rats fed a high-fat diet. Lipids Health Dis 2012, 11:148.
25. Zhang C.G., Jia Z.Q., Li B.H., Zhang H., Liu Y.N., Chen P., et al. beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem. Biophys. Res. Commun 2009, 390:258-262.
26. Zhang L., Malik S., Pang J., Wang H., Park K.M., Yule D.I., et al. Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell 2013, 153:216-227.
27. Zou J., Le K., Xu S., Chen J., Liu Z., Chao X., et al. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4. Mol. Cell. Endocrinol 2013, 370:103-112.
28. Zou J., Li H., Chen X., Zeng S., Ye J., Zhou C., et al. C/EBPbeta knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NfkappaB. Mol. Cell. Endocrinol 2014, 390:18-25.